Allergan saga takes another twist

The sovereign immunity defence for IPRs has garnered much attention, with the final chapter likely ending up at SCOTUS. Last September, Allergan and the Saint Regis Mohawk Tribe (tribe) entered into an agreement, under which Allergan transferred certain patents directed to an eye treatment drug called Restasis to the tribe and, in turn, the tribe licensed the patents back to Allergan.

Read more: Allergan saga takes another twist


Download PDF Share Back To Listing
Loading data